Skip to main content
Article
Trends and outcomes associated with angiotensin-converting enzyme inhibitors
Quantitative Health Sciences Publications and Presentations
  • Chyke A. Doubeni, University of Massachusetts Medical School
  • Carol Bigelow, University of Massachusetts, Amherst
  • Darleen M. Lessard, University of Massachusetts Medical School
  • Frederick A. Spencer, University of Massachusetts Medical School
  • Jorge L. Yarzebski, University of Massachusetts Medical School
  • Joel M. Gore, University of Massachusetts Medical School
  • Jerry H. Gurwitz, University of Massachusetts Medical School
  • Robert J. Goldberg, University of Massachusetts Medical School
UMMS Affiliation
Department of Medicine, Division of Cardiovascular Medicine; Department of Quantitative Health Sciences; Meyers Primary Care Institute; Department of Medicine, Division of Geriatric Medicine; Department of Family Medicine and Community Health
Date
7-11-2006
Document Type
Article
Medical Subject Headings
Aged; Aged, 80 and over; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy; Female; Hospitalization; Humans; Male; Massachusetts; Middle Aged; Myocardial Infarction; Odds Ratio; Treatment Outcome
Abstract
BACKGROUND: Limited recent data are available describing the patterns of use of angiotensin converting enzyme inhibitor (ACEI) therapy in patients with acute myocardial infarction (AMI), particularly from the more generalizable population-based setting. The purpose of this study was to examine trends in the receipt of ACEIs and associated short-term outcomes in patients hospitalized with AMI in a large Northeastern community. METHODS: We conducted a community-wide study of 7991 patients hospitalized with AMI in all metropolitan Worcester, Massachusetts, medical centers during 8 annual periods between 1990 and 2003. RESULTS: Among all patients, 44% received ACEI therapy during their acute hospitalization. There was a marked increase in the use of ACEIs between 1990 (23%) and 2003 (68%), particularly among those who were not on ACEIs before hospitalization. Patients who were previously on ACEIs were more likely to receive this therapy during hospitalization for AMI than were patients who were not previously on this therapy. Patients treated with ACEIs were significantly less likely to die (adjusted odds ratio [OR] 0.33; 95% confidence interval [CI] 0.27-0.41) during hospitalization than were patients who did not receive this therapy, with benefits observed across all subgroups examined. CONCLUSIONS: The results of this observational study demonstrate marked increases in the use of ACEIs in patients with AMI in the community setting and demonstrate the benefits to be gained from use of this therapy. Despite these encouraging trends, there remains room for more optimal use of this therapy.
Rights and Permissions
Citation: Am J Med. 2006 Jul;119(7):616.e9-16. Link to article on publisher's site
Related Resources
Link to Article in PubMed
Citation Information
Chyke A. Doubeni, Carol Bigelow, Darleen M. Lessard, Frederick A. Spencer, et al.. "Trends and outcomes associated with angiotensin-converting enzyme inhibitors" Vol. 119 Iss. 7 (2006) ISSN: 0002-9343 (Linking)
Available at: http://works.bepress.com/jorge_yarzebski/15/